AdaptHealth Corp. (NASDAQ: AHCO) reported Q4 EPS of $0.15, $0.19 worse than the analyst estimate of $0.34. Revenue for the quarter came in at $702.1 million versus the consensus estimate of $689.66 million.

GUIDANCE:

AdaptHealth Corp. sees FY2022 revenue of $2.825-3.025 billion, versus the consensus of $2.85 billion.

• Adjusted EBITDA of $610 million to $670 million, vs. prior guidance of $635 million to $695 million; and
• Total capital expenditures representing 9-11% of net revenue, unchanged vs. prior guidance.

For earnings history and earnings-related data on AdaptHealth Corp. (AHCO) click here.